Literature DB >> 21615650

Infant anthropometry, early life infection, and subsequent risk of type 1 diabetes mellitus: a prospective birth cohort study.

Anne-Louise Ponsonby1, Angela Pezic, Jennifer Cochrane, Fergus J Cameron, Mark Pascoe, Andrew Kemp, Terence Dwyer.   

Abstract

BACKGROUND: Higher birthweight is associated with increased type 1 diabetes mellitus (T1DM) risk, but the contribution of higher adiposity or lean mass is unclear. In this Tasmanian infant cohort, early upper respiratory infection has been associated with higher asthma risk. PATIENTS AND METHODS: Eligible infants represented one-fifth of live births in Tasmania, 1988-1995. Hospital interview data (day 6) were obtained on 96.3% (10 628/11 040), home (5 wk) visit data (38 d) on 92.9% (9876/10 628) of those, then a phone (12 wk) interview (87 d). Tricep and subscapular skinfold measures and upper arm circumference were recorded at the first two interviews. T1DM cases (n = 26) arising from the age of 16 or under in Tasmania from 1988 to 2006 were ascertained.
RESULTS: Higher birthweight [adjusted odds ratio (AOR) 2.82 (95% CI 1.31-6.09)], lean mid-upper arm circumference [AOR 1.76 (95% CI 1.16-2.66)], not skinfold measures, were associated with T1DM risk. Children with an early upper respiratory tract infection by 5-wk visit [AOR 2.74 (95% CI 1.19-6.32)] or ear infection by 12-wk interview [AOR 3.44 (95% CI 1.00-11.79)] were also at higher risk. Putative markers of altered microbial exposure such as resident density were not associated with T1DM risk but the effect of increasing birth order on T1DM risk differed for older (AOR 0.41, p = 0.02) than young mother (AOR 2.45, p = 0.01); difference in effect, p = 0.001.
CONCLUSION: In this cohort, early upper respiratory tract infection was associated with T1DM risk, as had been previously found for asthma, consistent with immunoinflammatory upregulation. Using the detailed anthropometric measures available, the link between higher birthweight and T1DM did not appear to reflect increased adiposity.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21615650     DOI: 10.1111/j.1399-5448.2010.00693.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  5 in total

Review 1.  Type 1 diabetes-early life origins and changing epidemiology.

Authors:  Jill M Norris; Randi K Johnson; Lars C Stene
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-27       Impact factor: 32.069

Review 2.  Early-life factors contributing to type 1 diabetes.

Authors:  Maria E Craig; Ki Wook Kim; Sonia R Isaacs; Megan A Penno; Emma E Hamilton-Williams; Jennifer J Couper; William D Rawlinson
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

3.  Breastfeeding, nutrition and type 1 diabetes: a case-control study in Izmir, Turkey.

Authors:  İpek Çiçekli; Raika Durusoy
Journal:  Int Breastfeed J       Date:  2022-05-27       Impact factor: 3.790

4.  Infant Feeding and Risk of Type 1 Diabetes in Two Large Scandinavian Birth Cohorts.

Authors:  Nicolai A Lund-Blix; Stine Dydensborg Sander; Ketil Størdal; Anne-Marie Nybo Andersen; Kjersti S Rønningen; Geir Joner; Torild Skrivarhaug; Pål R Njølstad; Steffen Husby; Lars C Stene
Journal:  Diabetes Care       Date:  2017-05-09       Impact factor: 19.112

5.  Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies.

Authors:  Chris R Cardwell; Lars C Stene; Johnny Ludvigsson; Joachim Rosenbauer; Ondrej Cinek; Jannet Svensson; Francisco Perez-Bravo; Anjum Memon; Suely G Gimeno; Emma J K Wadsworth; Elsa S Strotmeyer; Michael J Goldacre; Katja Radon; Lee-Ming Chuang; Roger C Parslow; Amanda Chetwynd; Kyriaki Karavanaki; Girts Brigis; Paolo Pozzilli; Brone Urbonaite; Edith Schober; Gabriele Devoti; Sandra Sipetic; Geir Joner; Constantin Ionescu-Tirgoviste; Carine E de Beaufort; Kirsten Harrild; Victoria Benson; Erkki Savilahti; Anne-Louise Ponsonby; Mona Salem; Samira Rabiei; Chris C Patterson
Journal:  Diabetes Care       Date:  2012-07-26       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.